PROC - Procaps Quarterly EPS earnings growth

Symbol and logo of brand Procaps Group Corp (PROC)

Procaps Group S.A. (PROC) dominates the drug delivery systems sector, leveraging vertical integration and Latin American markets. The quarterly EPS growth trend shows a pivot driven by the implementation of ESG standards and global demand for Softgel technologies. Currently, -64.00 represents the latest level, confirming the earnings per share dynamics and the company's alignment with its established growth rates.

Procaps (PROC) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 02/16/2025

Procaps Group Corp (PROC) - metric breakdowns and financial figures

- share price and expert price forecast:
Stock Price Procaps|PROC - Fair Value Consensus
- market capitalization statistics:
Market Capitalization Procaps Group SA|PROC - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Procaps|PROC - Accounting Value of Company|Market Value to Book Value Ratio procapsgroup.com|PROC - Total Asset Value of Company
- company liabilities and liquidity data:
Debt to Equity Procaps Group S.A.|PROC - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Procaps Group S.A.|PROC - Company Cumulative Debt|Debts to Book Capitalization Procaps Group SA|PROC - Company Long-Term Liabilities|Company Short-Term Debts Procaps|Quick Liquidity procapsgroup.com
- earnings and market multiples details:
PROC - Profit After Tax|Expected Profit Procaps Group S.A.|PROC - Business Payback Period|Projected Price to Earnings Procaps Group SA|PROC - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Procaps Group SA|PROC - Operating profit before depreciation charges|Earnings per share for the last twelve months Procaps|PROC - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months procapsgroup.com|PROC - Earnings per share growth rate in current year|Expected earnings per share growth for next year Procaps Group S.A.
Comprehensive company analysis:Procaps - PROC
Manufactured product of Procaps Group S.A.

This indicator measures the percentage change in net earnings per share per quarter, allowing for an assessment of capital generation efficiency relative to the previous period. By analyzing the quarterly EPS growth rate, an investor can determine how successfully Procaps Group S.A. (PROC) monetizes the contract manufacturing of innovative capsules and dietary supplements for global pharma behemoths, separating sustainable business growth from market volatility.

Main competitors

HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|ALVO (Alvotech S.A.) - Year-over-year net earnings per share trend for the last twelve months|LQDA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months GLPG (Galapagos Corp)|ANI Pharmaceuticals (ANIP) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months mannkindcorp.com (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Pacira Pharmaceuticals (PCRX)|Quarterly EPS earnings growth SPRY|Quarterly EPS earnings growth Theravance Corp (TBPH)|Year-over-year earnings per share growth for the last twelve months Aquestive Therapeutics AQST|SCPH (scPharmaceuticals, Inc.) - Year-over-year net earnings per share trend for the last twelve months|TECX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Tonix Pharma TNXP|SXTC (sxtchina.com) - Year-over-year net earnings per share growth for the last 12 months|Eupraxia Pharmaceuticals Inc. - Year-over-year earnings per one share growth for the last 12 months|BHST (BioHarvest Sciences) - Quarterly EPS earnings growth|EXOZ - Net earnings per share growth for the trailing year|Year-over-year earnings per share growth for the last twelve months Oramed Pharmaceuticals (ORMP)|ENTX (enterabio.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MindWalk HYFT|ABVC BioPharma, Inc (ABVC) - Earnings per share growth in annualized terms for the last twelve months|CPIX: Year-over-year net earnings per share growth for the last 12 months|QNTM - Quarterly EPS earnings growth|FibroGen (FGEN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months TELO (Telomir Pharmaceuticals Inc)|Year-over-year net earnings per share growth for the last 12 months RANI|SNYR: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Rallybio Corporation (RLYB)|Year-over-year net earnings per share change for the last twelve months lexariabioscience.com|Pulmatrix - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Pheton Holdings Limited (PTHL)|Aptorum - Quarterly EPS earnings growth|LYRA - Quarterly EPS earnings growth|IBO (Impact BioMedical) - Year-over-year net earnings per share growth for the last 12 months|TNFA - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months cbdMD Inc.|PainReform Ltd - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Altamira Therapeutics (CYTO)|LIPO (Lipella Pharma) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months OptiNose, Inc. OPTN|pieris.com (PIRS) - Earnings per share growth in annualized terms for the last twelve months|Petros Pharmaceuticals, Inc. - Quarterly EPS earnings growth|Qilian International Holding Group (QLI) - Year-over-year net earnings per share growth for the last 12 months|ACELYRIN, Inc. (SLRN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months TFFP (TFF Pharmaceuticals, Inc)